Stay updated on Taletrectinib ROS1+ NSCLC Clinical Trial
Sign up to get notified when there's something new on the Taletrectinib ROS1+ NSCLC Clinical Trial page.

Latest updates to the Taletrectinib ROS1+ NSCLC Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedThe history now shows a new entry for Revision: v3.6.4, replacing the previous Revision: v3.6.3. This reflects a platform update to the record history and does not alter the study data or participant-facing details.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedAn updated revision entry v3.6.3 has been added to the study history, and the previous revision v3.6.2 has been removed.SummaryDifference0.1%

- Check39 days agoChange DetectedThe study record history now lists Revision: v3.6.2, replacing the older v3.6.0 entry and updating the page’s version history.SummaryDifference0.1%

- Check53 days agoChange DetectedThe history now shows that enrollment is closed for this study, and the latest version tag 'Revision: v3.6.0' has been added while the previous revision 'v3.5.5' was removed.SummaryDifference0.4%

- Check61 days agoChange DetectedRevision: v3.5.5 has been added to the history, replacing the previous v3.5.4, representing an updated version of the page’s historical record.SummaryDifference0.1%

- Check82 days agoChange DetectedThe page history now includes a new revision entry labeled v3.5.4, updating the release notes metadata for this study record.SummaryDifference0.1%

Stay in the know with updates to Taletrectinib ROS1+ NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Taletrectinib ROS1+ NSCLC Clinical Trial page.